Integrity Alliance’s Quest Diagnostics DGX Stock Holding History

Integrity Alliance’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.69M	Buy	7,993 +69	+0.9%	+$13.5K	0.05%	252
2026 Q1	$1.55M	Sell	7,924 -53	-0.7%	-$10.3K	0.06%	237
2025 Q4	$1.38M	Sell	7,977 -804	-9%	-$146K	0.05%	266
2025 Q3	$1.67M	Buy	8,781 +3,287	+60%	+$583K	0.08%	189
2025 Q2	$987K	Sell	5,494 -8,294	-60%	-$1.44M	0.05%	221
2025 Q1	$2.33M	Buy	13,788 +4,716	+52%	+$775K	0.09%	170
2024 Q4	$1.37M	Buy	+9,072	New	+$1.41M	0.15%	86

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Integrity Alliance's DGX Position: Q2 2026 in Review

Integrity Alliance increased its Quest Diagnostics (DGX) stake by 0.87% in Q2 2026, buying an estimated $13.5K and bringing the position to 7,993 shares worth $1.69M. The position accounts for 0.05% of the portfolio, ranked #252.

Integrity Alliance first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.33M in Q1 2025. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Integrity Alliance held 7,993 shares of Quest Diagnostics worth $1.69M as of Q2 2026.
Integrity Alliance bought 69 Quest Diagnostics shares in Q2 2026, an estimated $13.5K.
Quest Diagnostics made up 0.05% of Integrity Alliance's portfolio in Q2 2026, its #252 holding.
Integrity Alliance first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
Integrity Alliance's Quest Diagnostics position peaked at $2.33M in Q1 2025.
1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Integrity Alliance's 13F filing for Q2 2026, filed 31 Jul 2026.